BSG and viral infectious disease: CD147, recognized as a universal receptor for the spike protein of SARS-CoV-2 and its variants, plays a pivotal role in facilitating viral infection.20 Meplazumab, an antibody targeting CD147, has demonstrated the capability to effectively block viral entry and replication, which is not compromised by the variants of SARS-CoV-2.22